In force Publication date 06 May 15

Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth

Resource description

Project Title: Development of ultrasensitive DNA aptamer-based tests for pharmaceutical grade recombinant human growth hormone

Researcher: Dr. Bruno

Institution: Operational Technologies Corp, USA

Year approved: 2011

Summary: Under this follow on grant proposal, OpTech will develop a new set of discriminatory aptamers against one or more pharmaceutical grade recombinant hGH targets (Genotropin, Norditropin, etc.).

Download options

Available in 1 language.